Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Knapp

Showing results (231-240 of 305) with videos related to

Pageof 31
Sort By:
Obstetrics and Gynecology|November 1, 1984
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancerJ S Berek, R C Bast, A Lichtenstein, et al.
Gynecologic Oncology|September 1, 1992
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaH M Goodman, B L Harlow, E E Sheets, et al.
American Journal of Obstetrics and Gynecology|July 1, 1984
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenR C Bast, T L Klug, E Schaetzl, et al.
Gynecologic Oncology|May 1, 1988
An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaV R Zurawski, R C Knapp, N Einhorn, et al.
Cancer|October 25, 1991
Coordinate elevation of serum markers in ovarian cancer but not in benign diseaseR C Bast, S Knauf, A Epenetos, et al.
Gynecologic Oncology|September 1, 1985
Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinomaR C Bast, F P Siegal, C Runowicz, et al.
Differentiation; Research in Biological Diversity|December 1, 1989
Cytokeratins and cytokeratin filaments in subpopulations of cultured human and rodent cells of nonepithelial origin: modes and patterns of formationA C Knapp, F X Bosch, M Hergt, et al.
Plos One|October 12, 2012
Genetic diversity of neotropical Myotis (chiroptera: vespertilionidae) with an emphasis on South American speciesRoxanne J Larsen, Michelle C Knapp, Hugh H Genoways, et al.
Gynecologic Oncology|July 1, 1989
Predictive factors for long-term survival in patients with advanced ovarian cancerK J Krag, G P Canellos, C T Griffiths, et al.
Gynecologic Oncology|February 1, 1990
CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancerV J Hunter, J B Weinberg, A F Haney, et al.
Pageof 31

Showing results (231-240 of 305) with videos related to

Sort By:
Pageof 31
Obstetrics and Gynecology|November 1, 1984
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancerJ S Berek, R C Bast, A Lichtenstein, et al.
Gynecologic Oncology|September 1, 1992
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaH M Goodman, B L Harlow, E E Sheets, et al.
American Journal of Obstetrics and Gynecology|July 1, 1984
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenR C Bast, T L Klug, E Schaetzl, et al.
Gynecologic Oncology|May 1, 1988
An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaV R Zurawski, R C Knapp, N Einhorn, et al.
Cancer|October 25, 1991
Coordinate elevation of serum markers in ovarian cancer but not in benign diseaseR C Bast, S Knauf, A Epenetos, et al.
Gynecologic Oncology|September 1, 1985
Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinomaR C Bast, F P Siegal, C Runowicz, et al.
Differentiation; Research in Biological Diversity|December 1, 1989
Cytokeratins and cytokeratin filaments in subpopulations of cultured human and rodent cells of nonepithelial origin: modes and patterns of formationA C Knapp, F X Bosch, M Hergt, et al.
Plos One|October 12, 2012
Genetic diversity of neotropical Myotis (chiroptera: vespertilionidae) with an emphasis on South American speciesRoxanne J Larsen, Michelle C Knapp, Hugh H Genoways, et al.
Gynecologic Oncology|July 1, 1989
Predictive factors for long-term survival in patients with advanced ovarian cancerK J Krag, G P Canellos, C T Griffiths, et al.
Gynecologic Oncology|February 1, 1990
CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancerV J Hunter, J B Weinberg, A F Haney, et al.
Pageof 31